The growing focus on patient outcomes and population health, along with the growing complexity of care, are disrupting how healthcare is delivered, how decisions are made, and how scientific data and drug information are used. These trends also present an opportunity for pharmaceutical companies to develop their Medical Affairs organizations into more strategic stewards of patient outcomes.
By refining the role of Medical Affairs from disease and product specialists to curators and connectors of outcomes-focused information, the Medical Affairs workforce of the future can help today’s extended ecosystem of providers, stakeholders and decision-makers capture, understand and use science to support better decisions—from the boardroom to the bedside.
DOWNLOAD GOOD SCIENCE: THE NEW ROLE OF MEDICAL AFFAIRS IN AN OUTCOMES-FOCUSED WORLD [PDF]
Comment submitted
Submitted comment may not display automatically.